From LinkedOmics, we found that elevated BAIAP2L2 expression predicted worse OS in adrenocortical carcinoma (ACC) (p = 6.724e-03), LIHC (p = 1.108e-03), LUAD (p = 1.430e-03), mesothelioma (MESO) (p = 3.436e-03), PRAD (p = 5.183e-03), uveal melanoma (UVM) (p = 1.706e-03) and good OS in glioma (p = 2.587e-14) and brain lower grade glioma (LGG) (p = 2.797e-04) (Figure 2C). Here, BAIAP2L2 is linked to prostate adenocarcinoma.